Company and People Notes: Chesapeake to Relocate and Expand, AVI BioPharma Appoints CEO, More

Seladelpar, which is marketed in the US as Livdelzi, was recommended for an orphan drug designation by CHMP in December 2024.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

A capsule formulation may offer more consistent and reliable uptake versus a syringe, while being less dependent on food intake.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.

The agency has received certification with the Eco-Management and Audit Scheme for its commitment to environmental sustainability.